
Alto Neuroscience, Inc.
ANROHealthcare|Biotechnology|US
$25.16
+3.29 (+15.04%)
DCF Value
$5.91
Tangible Book / Share
$5.12
Cash / Share
$5.69
Next Earnings Report
Nov 11, 2026
EPS est. -$0.67
Financing Filings (last 12 months)
3
Shelf registrations / offering prospectuses — latest Jul 14, 2026 (424B5). Possible dilution.
Upcoming Data Readouts (3)
Dec 2026
Est. completion
Sep 2027
Est. completion
P2Bipolar Disorder I or II With a Major Depressive Episode
ALTO-100 in Bipolar Disorder With Depression (BD-D)
NCT06656416n=200
Nov 2027
Est. completion
P2Treatment-resistant Depression (TRD)
ALTO-207 in Adults With Treatment-resistant Depression (TRD)
NCT07553637n=178
Recent Press Releases
Alto Neuroscience Announces New Employee Inducement Grants Under NYSE Rule 303A.08
Nov 4, 2026 · Business Wire
Alto Neuroscience Announces Participation in Upcoming Investor Conferences
Sep 9, 2026 · Business Wire
Alto Neuroscience Promotes Nick Smith to President and Chief Financial Officer
Aug 27, 2026 · Business Wire
Alto Neuroscience Reports Second Quarter 2026 Financial Results and Recent Business Highlights
Aug 12, 2026 · Business Wire
SEC Filings (77)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Oct 30, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Aug 27, 2026 | 8-K | Material event | DocumentIndex |
| Aug 14, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Aug 14, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Aug 14, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Aug 12, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Aug 12, 2026 | 8-K | Material event | DocumentIndex |
| Jul 27, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Jul 20, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Jul 14, 2026 | 8-K | Material event | DocumentIndex |
| Jul 14, 2026 | 424B5 | Offering prospectus | DocumentIndex |
| Jul 13, 2026 | 8-K | Material event | DocumentIndex |
| May 28, 2026 | 8-K | Material event | DocumentIndex |
| May 15, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| May 15, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| May 15, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| May 15, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| May 13, 2026 | 8-K | Material event | DocumentIndex |
| May 13, 2026 | 10-Q | Quarterly report | DocumentIndex |
| May 13, 2026 | 8-K | Material event | DocumentIndex |
| Apr 20, 2026 | EFFECT | DocumentIndex | |
| Apr 10, 2026 | S-3 | Shelf registration | DocumentIndex |
| Apr 1, 2026 | 8-K | Material event | DocumentIndex |
| Mar 26, 2026 | ARS | Annual report to holders | DocumentIndex |
| Mar 26, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Mar 26, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Mar 16, 2026 | 8-K | Material event | DocumentIndex |
| Mar 16, 2026 | S-8 | Employee stock plan | DocumentIndex |
| Mar 16, 2026 | 10-K | Annual report | DocumentIndex |
| Mar 16, 2026 | 8-K | Material event | DocumentIndex |
| Feb 18, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Feb 17, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Feb 17, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Feb 17, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Feb 17, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Feb 17, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Feb 17, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Dec 10, 2025 | EFFECT | DocumentIndex | |
| Nov 28, 2025 | S-3 | Shelf registration | DocumentIndex |
| Nov 12, 2025 | 10-Q | Quarterly report | DocumentIndex |